1
|
Lazarus GS, Cooper DM, Knighton DR,
Percoraro RE, Rodeheaver G and Robson MC: Definitions and
guidelines for assessment of wounds and evaluation of healing.
Wound Repair Regen. 2:165–170. 1994. View Article : Google Scholar : PubMed/NCBI
|
2
|
Boateng JS, Matthews KH, Stevens HN and
Eccleston GM: Wound healing dressings and drug delivery systems: A
review. J Pharm Sci. 97:2892–2923. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Seshareddy K, Troyer D and Weiss ML:
Method to isolate mesenchymal-like cells from Wharton's Jelly of
umbilical cord. Methods Cell Biol. 86:101–119. 2008. View Article : Google Scholar : PubMed/NCBI
|
4
|
Banerjee J, Chan YC and Sen CK: MicroRNAs
in skin and wound healing. Physiol Genomics. 43:543–556. 2011.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Sand M, Gambichler T, Sand D, Skrygan M,
Altmeyer P and Bechara FG: MicroRNAs and the skin: Tiny players in
the body's largest organ. J Dermatol Sci. 53:169–175. 2009.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Xiao X, Tang C, Xiao S, Fu C and Yu P:
Enhancement of proliferation and invasion by microRNA-590-5p via
targeting PBRM1 in clear cell renal carcinoma cells. Oncol Res.
20:537–544. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Jiang X, Xiang G, Wang Y, Zhang L, Yang X,
Cao L, Peng H, Xue P and Chen D: MicroRNA-590-5p regulates
proliferation and invasion in human hepatocellular carcinoma cells
by targeting TGF-b RII. Mol Cells. 33:545–551. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Shan X, Miao Y, Fan R, Qian H, Chen P, Liu
H, Yan X, Li J and Zhou F: MiR-590-5P inhibits growth of HepG2
Cells via decrease of S100A10 expression and inhibition of the Wnt
pathway. Int J Mol Sci. 14:8556–8569. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Chu Y, Ouyang Y, Wang F, Zheng A, Bai L,
Han L, Chen Y and Wang H: MicroRNA-590 promotes cervical cancer
cell growth and invasion by targeting CHL1. J Cell Biochem.
115:847–853. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Li K, Li Z, Zhao N and Xu Y, Liu Y, Zhou
Y, Shang D, Qiu F, Zhang R, Chang Z and Xu Y: Functional analysis
of microRNA and transcription factor synergistic regulatory network
based on identifying regulatory motifs in non-small cell lung
cancer. BMC Syst Biol. 7:1222013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lee S, Yu KR, Ryu YS, Oh YS, Hong IS, Kim
HS, Lee JY, Kim S, Seo KW and Kang KS: miR-543 and miR-590-3p
regulate human mesenchymal stem cell aging via direct targeting of
AIMP3/p18. Age (Dordr). 36:97242014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Shan H, Zhang Y, Lu Y, Zhang Y, Pan Z, Cai
B, Wang N, Li X, Feng T, Hong Y and Yang B: Downregulation of
miR-133 and miR-590 contributes to nicotine-induced atrial
remodelling in canines. Cardiovasc Res. 83:465–472. 2009.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Kavsak P, Rasmussen RK, Causing CG, Bonni
S, Zhu H, Thomsen GH and Wrana JL: Smad7 binds to Smurf2 to form an
E3 ubiquitin ligase that targets the TGF beta receptor for
degradation. Mol Cell. 6:1365–1375. 2000. View Article : Google Scholar : PubMed/NCBI
|
15
|
Fukasawa H, Yamamoto T, Togawa A, Ohashi
N, Fujigaki Y, Oda T, Uchida C, Kitagawa K, Hattori T, Suzuki S, et
al: Down-regulation of Smad7 expression by ubiquitin-dependent
degradation contributes to renal fibrosis in obstructive
nephropathy in mice. Proc Natl Acad Sci USA. 101:8687–8692. 2004.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Afrakhte M, Morén A, Jossan S, Itoh S,
Sampath K, Westermark B, Heldin CH, Heldin NE and ten Dijke P:
Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family
members. Biochem Biophys Res Commun. 249:505–511. 1998. View Article : Google Scholar : PubMed/NCBI
|
17
|
Jia J, Feng X, Xu W, Yang S, Zhang Q, Liu
X, Feng Y and Dai Z: MiR-17-5p modulates osteoblastic
differentiation and cell proliferation by targeting SMAD7 in
non-traumatic osteonecrosis. Exp Mol Med. 46:e1072014. View Article : Google Scholar : PubMed/NCBI
|
18
|
Liu G, Friggeri A, Yang Y, Milosevic J,
Ding Q, Thannickal VJ, Kaminski N and Abraham E: miR-21 mediates
fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J
Exp Med. 207:1589–1597. 2010. View Article : Google Scholar : PubMed/NCBI
|
19
|
Chen G, Cao S, Liu F and Liu Y: miR-195
plays a role in steroid resistance of ulcerative colitis by
targeting Smad7. Biochem J. 471:357–367. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhu B, Wei XX, Wang TB, Zhou YC, Liu AM
and Zhang GW: Increased miR-16 expression induced by hepatitis C
virus infection promotes liver fibrosis through downregulation of
hepatocyte growth factor and Smad7. Arch Virol. 160:2043–2050.
2015. View Article : Google Scholar : PubMed/NCBI
|
21
|
Wang ZH, Zhang QS, Duan YL, Zhang JL, Li
GF and Zheng DL: TGF-β induced miR-132 enhances the activation of
TGF-β signaling through inhibiting SMAD7 expression in glioma
cells. Biochem Biophys Res Commu. 463:187–192. 2015. View Article : Google Scholar
|
22
|
Liu N, Jiao T, Huang Y, Liu W, Li Z and Ye
X: Hepatitis B virus regulates apoptosis and tumorigenesis through
the microRNA-15a-Smad7-transforming growth factor β pathway. J
Virol. 89:2739–2749. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Liu J, Yao W, Yao Y, Du X, Zhou J, Ma B,
Liu H, Li Q and Pan Z: miR-92a inhibits porcine ovarian granulosa
cell apoptosis by targeting Smad7 gene. FEBS Lett. 588:4497–4503.
2014. View Article : Google Scholar : PubMed/NCBI
|
24
|
Trang NV, Choisy M, Nakagomi T, Chinh NT,
Doan YH, Yamashiro T, Bryant JE, Nakagomi O and Anh DD:
Determination of cut-off cycle threshold values in routine RT-PCR
assays to assist differential diagnosis of norovirusin children
hospitalized for acute gastroenteritis. Epidemiol Infect.
143:3292–3299. 2015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Su Y, Yang CY, Li Z, Xu F, Zhang L, Wang F
and Zhao S: Smad7 siRNA inhibit expression of extracellular matrix
intrabecular meshwork cells treated with TGF-β2. Mol Vis.
18:1881–1884. 2012.PubMed/NCBI
|
26
|
Shakespeare P: Burn wound healing and skin
substitutes. Burns. 27:517–522. 2001. View Article : Google Scholar : PubMed/NCBI
|
27
|
Newman RE, Yoo D, LeRoux MA and
Danilkovitch-Miagkova A: Treatment of inflammatory diseases with
mesenchymal stem cells. Inflamm Allergy Drug Targets. 8:110–123.
2009. View Article : Google Scholar : PubMed/NCBI
|
28
|
Arno AI, Amini-Nik S, Blit PH, Al-Shehab
M, Belo C, Herer E, Tien CH and Jeschke MG: Human Wharton's
jelly-mesenchymal stem cells promote skin wound healing through
paracrine signaling. Stem Cell Res Ther. 5:282014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Bushati N and Cohen SM: microRNA
functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
|
30
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
31
|
He PP, OuYang XP, Li Y, Lv YC, Wang ZB,
Yao F, Xie W, Tan YL, Li L, Zhang M, et al: MicroRNA-590 inhibits
lipoprotein lipase expression and prevents atherosclerosis in apoE
knockout mice. PLoS One. 10:e01387882015. View Article : Google Scholar : PubMed/NCBI
|
32
|
Zhao S, Yang G, Liu PN, Deng YY, Zhao Z,
Sun T, Zhuo XZ, Liu JH, Tian Y, Zhou J, et al: miR-590-3p is a
novel MicroRNA in myocarditis by targeting nuclear factor Kappa-B
in vivo. Cardiology. 132:182–188. 2015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Sundaram GM, Common JE, Gopal FE, Srikanta
S, Lakshman K, Lunny DP, Lim TC, Tanavde V, Lane EB and Sampath P:
'See-saw' expression of microRNA-198 and FSTL1 from a single
transcript in wound healing. Nature. 495:103–106. 2013. View Article : Google Scholar : PubMed/NCBI
|